By Mark DeCambre and Joy Wiltermuth
The Dow Jones Industrial Average and the S&P 500 booked their first positive close in six sessions Monday, with the blue-chip index scoring its best daily gain in about five weeks, according to Dow Jones Market Data.
The Nasdaq Composite ended 1% lower, extending its losing streak to a fourth session in a row.
What happened in stocks
The Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +1.47% rose 261.91 points, or 0.8%, to end at 34,869.63.
The S&P 500 /zigman2/quotes/210599714/realtime SPX +2.39% gained 10.15 points, or 0.2%, closing at 4,468.73, but off its intraday high at 4,492.99.
The Nasdaq Composite Index /zigman2/quotes/210598365/realtime COMP +3.82% fell 9.91 points, or 0.1%, finishing at 15,105.58.
Last week, the Dow industrials dropped 2.2%, the S&P 500 lost 1.7% and the Nasdaq Composite retreated by 1.6%. For both the Dow and the S&P, it was the worst week since the period ending June 18; both indexes also fell for five straight sessions.
What drove markets
The Dow and S&P 500 rose Monday, while the Nasdaq finished lower, with selling in healthcare, growth and value stocks weighing on equities.
“We are basically in a drifting market,” said Peter Cardillo, chief market economist at Spartan Capital Securities, pointing to modest gains Monday for the Dow and small-cap stocks, but pressure on the Nasdaq Composite.
“What we are seeing here is basically a market that’s very much gripped by seasonal factors,” Cardillo said, in a phone interview. “We have had four or five days of declines. But the decline has been without any major volumes. That’s a good sign, which means the market isn’t likely to encounter any serious decline during the month of September.”
There weren’t any major developments on the economic or corporate front, ahead of more fireworks on Tuesday, when consumer price data will be released and Apple Inc . /zigman2/quotes/202934861/composite AAPL +3.19% will unveil its new suite of upgraded products.
Supply-chain worries, as well as the delta variant of coronavirus, were two factors behind last week’s stock-market retreat.
“Throughout the pandemic, vaccination has been key to both lifting social restrictions and local market performance,” wrote Seema Shah, chief strategist at Principal Global Investors, in a note.
“In the United States, where the S&P 500 is up more than 20% YTD, an early and aggressive vaccination rollout has allowed for the full reopening of its economy,” the strategist wrote.
Investors also have remained on edge as valuations have been perceived as lofty and due for a pullback.
An investor survey conducted by Deutsche Bank found more than two-thirds of respondents expecting at least a 5% decline in stocks by the end of the year. The same survey found the biggest risks to the market are new variants that bypass vaccines, and higher than expected inflation or bond yields.